Buchumschlag

The PATCH trial: 5% lidocaine‐medicated plaster for trigeminal neuralgia—Results of a multicentric, enriched enrollment, randomized withdrawal, double‐blind, vehicle‐controlled, parallel‐group study

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chunmei Zhao, Niti Shrestha, Hao Ren, Baohui Zhang, Ying Shen, Lan Meng, Dasheng Wu, Baoguo Wang, Bifa Fan, Fang Luo
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Intravenous magnesium and methocarbamol for acute pain crises in refractory trigeminal neuralgia: A retrospective analysis
von: Bradley Ong, et al.
Veröffentlicht: (2025)

Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen
von: Albert Muñoz‐Vendrell, et al.
Veröffentlicht: (2025)

Comment on “Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen”
von: Alcántara Montero A
Veröffentlicht: (2025)

Authors’ response to comment on “Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen”
von: Albert Muñoz‐Vendrell, et al.
Veröffentlicht: (2025)

A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study
von: Gregory A. Panza, et al.
Veröffentlicht: (2024)

Management of nummular headache with local lidocaine: A case report
von: Esra Kochan Kizilkilic
Veröffentlicht: (2026)

Regulation of headache response and transcriptomic network by the trigeminal ganglion clock
von: Chorong Han, et al.
Veröffentlicht: (2024)

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
von: Muneto Tatsumoto, et al.
Veröffentlicht: (2024)

TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms
von: Philip V. Reducha, et al.
Veröffentlicht: (2025)

Neuralgia in the occipital region associated with ipsilateral trigeminal herpes zoster: Three case reports
von: Akihiko Nakaya, et al.
Veröffentlicht: (2024)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
von: Nathaniel M. Schuster, et al.
Veröffentlicht: (2025)

Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock
von: Chorong Han, et al.
Veröffentlicht: (2024)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
von: Koichi Ikeda, et al.
Veröffentlicht: (2025)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
von: Charly Gaul, et al.
Veröffentlicht: (2025)

Cortical synchronization of spontaneous trigeminal neuropathic pain monitored with in vivo optical imaging of calcium activity in freely moving mice
von: Qianxi Liu, et al.
Veröffentlicht: (2026)

Pain medication beliefs in individuals with headache
von: Dana P. Turner, et al.
Veröffentlicht: (2024)

Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Association: A pilot project
von: Larry Charleston
Veröffentlicht: (2024)

The use of artificial intelligence in headache medical and patient education: Generation of visual aids
von: Nisha A. Malhotra, et al.
Veröffentlicht: (2026)

Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache
von: Roemer B. Brandt, et al.
Veröffentlicht: (2025)

Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
von: Andrew Blumenfeld, et al.
Veröffentlicht: (2024)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
von: Jessica Ailani, et al.
Veröffentlicht: (2026)

Patient reported outcomes and the real‐world use of calcitonin gene–related peptide medications in migraine
von: Samuel K. Peasah, et al.
Veröffentlicht: (2024)

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial
von: Serena Laura Orr, et al.
Veröffentlicht: (2024)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
von: Richard B. Lipton, et al.
Veröffentlicht: (2025)

Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy ( MOTS ) trial
von: Samantha C. Shao, et al.
Veröffentlicht: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
von: Chia‐Chun Chiang, et al.
Veröffentlicht: (2024)

Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study
von: Elizabeth K. Seng, et al.
Veröffentlicht: (2024)

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study
von: David W. Dodick, et al.
Veröffentlicht: (2025)

Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials
von: Jennifer Robblee, et al.
Veröffentlicht: (2024)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
von: Dawn C. Buse, et al.
Veröffentlicht: (2026)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
von: Anna Gryglas‐Dworak, et al.
Veröffentlicht: (2024)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
von: Maggie R. Mittleman, et al.
Veröffentlicht: (2024)

Sex‐specific differences in the relationship between AHA Life's Essential 8 factors and migraine disorders: A cross‐sectional evaluation in ELSA ‐Brasil study
von: Arão Belitardo de Oliveira, et al.
Veröffentlicht: (2025)

Case report: Treatment of temporomandibular joint disorder pain with V3 nerve block procedure
von: Dean Zeldich, et al.
Veröffentlicht: (2025)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
von: Jessica Ailani, et al.
Veröffentlicht: (2024)

Welcoming Headache 's 2024 incoming class of Assistant Editors
von: Sarah M. Bobker
Veröffentlicht: (2024)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
von: Jeffrey D. Sharon, et al.
Veröffentlicht: (2024)

Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial
von: Henrike Goldstein, et al.
Veröffentlicht: (2025)

Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study
von: Seonyoung Kang, et al.
Veröffentlicht: (2024)

Comfort matters: A new strategy to ease injection pain during headache treatment procedures
von: Hannah F. J. Shapiro
Veröffentlicht: (2026)